Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Self-Administered Nitrous Oxide on Urodynamic Study Parameters
NCT05883332Phase 4Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Jan 2023
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of nitrous oxide in anxiety disorder and pain (2 arms), sponsored by Beth Israel Deaconess Medical Center. Primary endpoint: Maximum Cystometric Capacity. Started Jan 2023; status: completed.
02
Drugs
nitrous oxide
03
Conditions
anxiety disorderpain
Beyond the preview
Go deeper on NCT05883332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05883332.